Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Marshall

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
American Journal of Epidemiology|February 24, 2001
Predictive 5-year survivorship model of cystic fibrosisT G Liou, F R Adler, S C Fitzsimmons, et al.
The Journal of Biological Chemistry|May 25, 1991
Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional propertiesN V Rao, N G Wehner, B C Marshall, et al.
The Journal of Clinical Endocrinology and Metabolism|March 9, 2012
An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis FoundationV Tangpricha, A Kelly, A Stephenson, et al.
Cancer|June 15, 1986
Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoidsA Y Chang, J P Kuebler, K J Pandya, et al.
JAMA|December 26, 2001
Survival effect of lung transplantation among patients with cystic fibrosisT G Liou, F R Adler, B C Cahill, et al.
The Journal of Biological Chemistry|October 15, 1992
Structure, chromosomal assignment, and expression of the gene for proteinase-3. The Wegener's granulomatosis autoantigenA B Sturrock, K F Franklin, G Rao, et al.
The Journal of Clinical Investigation|April 1, 1993
Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expressionB C Marshall, A Santana, Q P Xu, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 1996
Tyloxapol inhibits NF-kappa B and cytokine release, scavenges HOCI, and reduces viscosity of cystic fibrosis sputumA J Ghio, B C Marshall, J L Diaz, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 17, 2015
Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care deliveryJ Abbott, J S Elborn, A M Georgiopoulos, et al.
The New England Journal of Medicine|January 8, 1999
Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study GroupB W Ramsey, M S Pepe, J M Quan, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
American Journal of Epidemiology|February 24, 2001
Predictive 5-year survivorship model of cystic fibrosisT G Liou, F R Adler, S C Fitzsimmons, et al.
The Journal of Biological Chemistry|May 25, 1991
Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional propertiesN V Rao, N G Wehner, B C Marshall, et al.
The Journal of Clinical Endocrinology and Metabolism|March 9, 2012
An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis FoundationV Tangpricha, A Kelly, A Stephenson, et al.
Cancer|June 15, 1986
Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoidsA Y Chang, J P Kuebler, K J Pandya, et al.
JAMA|December 26, 2001
Survival effect of lung transplantation among patients with cystic fibrosisT G Liou, F R Adler, B C Cahill, et al.
The Journal of Biological Chemistry|October 15, 1992
Structure, chromosomal assignment, and expression of the gene for proteinase-3. The Wegener's granulomatosis autoantigenA B Sturrock, K F Franklin, G Rao, et al.
The Journal of Clinical Investigation|April 1, 1993
Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expressionB C Marshall, A Santana, Q P Xu, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 1996
Tyloxapol inhibits NF-kappa B and cytokine release, scavenges HOCI, and reduces viscosity of cystic fibrosis sputumA J Ghio, B C Marshall, J L Diaz, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 17, 2015
Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care deliveryJ Abbott, J S Elborn, A M Georgiopoulos, et al.
The New England Journal of Medicine|January 8, 1999
Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study GroupB W Ramsey, M S Pepe, J M Quan, et al.
Pageof 3